TI
NRX

Turner Investments’s NEPHROGENEX INC COM NRX Stock Holding History

Turner Investments’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-369,188
Closed -$1.25M – 305
2015
Q3 		$1.25M Buy
369,188
+245,030
+197% +$1.08M 0.25% 121
2015
Q2 		$825K Buy
124,158
+1,454
+1% +$11K 0.15% 190
2015
Q1 		$965K Buy
+122,704
New +$963K 0.17% 156

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Turner Investments's NRX Position: Q4 2015 in Review

Turner Investments sold out of NEPHROGENEX INC COM (NRX) in Q4 2015, closing a stake of 369,188 shares — an estimated $1.25M sold.

Turner Investments first reported a position in NRX in Q1 2015 and held it in 3 quarters. The position peaked at $1.25M in Q3 2015. 15 funds tracked by Wall St. Rank hold NRX as of Q4 2015.

  • Turner Investments reported no remaining NEPHROGENEX INC COM position as of Q4 2015 after selling out during the quarter.
  • Turner Investments sold 369,188 NEPHROGENEX INC COM shares in Q4 2015, an estimated $1.25M.
  • Turner Investments first reported a position in NEPHROGENEX INC COM in Q1 2015 and held it in 3 quarters.
  • Turner Investments's NEPHROGENEX INC COM position peaked at $1.25M in Q3 2015.
  • 15 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q4 2015.

Based on Turner Investments's 13F filing for Q4 2015, filed 9 Feb 2016.